available for iOS, Android & web
May 01, 2012
Eli Lilly has underlined its commitment to the UK as a research base, and to neuroscience research in particular, by opening new early-stage facilities at its Erl Wood R&D centre in Surrey.
Making patients smile
Patients’ wellbeing can be just as important as
International Clinical Researcher of the Year 2016
Book your tickets today!
PharmaTimes 2015 Copyright | RSS Feed Subscriptions